NOTCH1 and breast cancer: Clementz et al. showed that Notch-1 and Notch-4 are novel targets of PEA3 in breast cancer cells and suggested that targeting PEA3 and Notch signaling pathways would provide a new therapeutic strategy for triple-negative and possibly other breast cancer subtypes (Clementz et al. 2011).